During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method. Cross-linking immunoprecipitation sequence https://mrna.creative-biolabs.com/clip-seq-for-rna-protein-interactions-analysis.htm
